Ken Fisher’s iTeos Therapeutics ITOS Stock Holding History

Ken Fisher’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,722	Closed	-$556K	–	1049
2025 Q2	$556K	Hold	55,722	–	–	﹤0.01%	775
2025 Q1	$333K	Buy	55,722 +20,507	+58%	+$151K	﹤0.01%	877
2024 Q4	$270K	Hold	35,215	–	–	﹤0.01%	890
2024 Q3	$360K	Hold	35,215	–	–	﹤0.01%	804
2024 Q2	$523K	Buy	+35,215	New	+$505K	﹤0.01%	777
2023 Q2	–	Sell	-102	Closed	-$1.39K	–	1185
2023 Q1	$1.39K	Buy	+102	New	+$1.83K	﹤0.01%	1124

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ken Fisher's ITOS Position: Q3 2025 in Review

Ken Fisher sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 55,722 shares — an estimated $556K sold.

Ken Fisher first reported a position in ITOS in Q1 2023 and held it in 6 quarters. The position peaked at $556K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Ken Fisher reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Ken Fisher sold 55,722 iTeos Therapeutics shares in Q3 2025, an estimated $556K.
Ken Fisher first reported a position in iTeos Therapeutics in Q1 2023 and held it in 6 quarters.
Ken Fisher's iTeos Therapeutics position peaked at $556K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.